Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma crisis: response to therapy

J M Richmond, A J D'Apice, K D Muirden

    The Medical Journal of Australia
    |May 31, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Overcoming hyperacute xenograft rejection with transgenic animals.

    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
    Same author

    Xenotransplantation: an update.

    Trends in cardiovascular medicine·2004
    Same author

    Effect of DNA concentration on transgenesis rates in mice and pigs.

    Transgenic research·2002
    Same author

    Genetic modification for xenotransplantation: transgenics and clones.

    Transplantation proceedings·2001
    Same author

    Blockade of the CD28 and CD40 pathways result in the acceptance of pig and rat islet xenografts but not rat cardiac grafts in mice.

    Transplant immunology·2001
    Same author

    Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters.

    Gene therapy·2001
    Same journal

    Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

    The Medical journal of Australia·2026
    Same journal

    Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

    The Medical journal of Australia·2026
    Same journal

    Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

    The Medical journal of Australia·2026
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    See all related articles

    Renal failure in systemic sclerosis is often irreversible. However, one patient with scleroderma and declining kidney function showed improvement with immunosuppressive therapy, plasma exchange, and blood pressure management.

    Area of Science:

    • Nephrology
    • Rheumatology
    • Immunology

    Background:

    • Systemic sclerosis (scleroderma) is a multisystem autoimmune disease characterized by fibrosis, vascular abnormalities, and immune dysregulation.
    • Renal involvement, specifically scleroderma renal crisis, is a serious complication that historically leads to irreversible renal failure.

    Observation:

    • Two cases of patients with systemic sclerosis and significant deterioration in renal function are presented.
    • One patient experienced a notable response to a multi-modal therapeutic approach.

    Findings:

    • The patient who responded to treatment received immunosuppressive agents, underwent plasma exchange, and had their blood pressure controlled.
    • This suggests that in select cases, renal failure associated with systemic sclerosis may not be entirely irreversible.

    Related Experiment Videos

    Implications:

    • These findings challenge the traditional view of irreversible renal failure in systemic sclerosis.
    • The presented therapeutic strategy may offer a potential avenue for improving renal outcomes in affected patients.
    • Further research is warranted to explore the efficacy and mechanisms of this treatment approach in a larger cohort.